Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 0 | 0 | 6,346 | 5,824 | 6,826 |
| Cost of Goods | N/A | N/A | 4,462 | 2,437 | 2,534 |
| Gross Profit | N/A | N/A | 1,884 | 3,387 | 4,292 |
| Operating Expenses | 10,404 | 11,162 | 15,939 | 15,951 | 17,270 |
| Operating Income | -10,404 | -11,162 | -13,593 | -12,127 | -12,444 |
| Other Income | -436 | -579 | -536 | -435 | -700 |
| Pre-tax Income | -10,840 | -11,741 | -14,129 | -12,562 | -13,144 |
| Net Income Continuous | -10,840 | -11,741 | -14,129 | -12,562 | -13,144 |
| Net Income Discontinuous | -2,492 | -277 | N/A | N/A | N/A |
| Net Income | $-13,332 | $-12,018 | $-14,129 | $-12,562 | $-13,144 |
| EPS Basic Total Ops | -132,158.60 | -243,886.80 | -0.63 | -0.55 | -0.58 |
| EPS Basic Continuous Ops | -107,578.40 | -238,140.80 | -0.63 | -0.55 | -0.58 |
| EPS Basic Discontinuous Ops | -24,580.22 | -5,746.03 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -132,158.60 | -243,886.80 | -0.63 | -0.55 | -0.58 |
| EPS Diluted Continuous Ops | -107,578.40 | -238,140.80 | -0.63 | -0.55 | -0.58 |
| EPS Diluted Discontinuous Ops | -24,580.22 | -5,746.03 | N/A | N/A | N/A |
| EBITDA(a) | $-9,831 | $-10,579 | $-12,987 | $-11,530 | $-11,844 |